Dr. Gillinder Bedi is a Senior Research Fellow in the Melbourne University Centre for Youth Mental Health and Orygen National Centre for Excellence in Youth Mental Health. She joined the University of Melbourne in 2017 to lead the development of a clinical drug and alcohol research program at Orygen.
Gill completed graduate training in clinical psychology at Monash University in Melbourne, Australia, investigating cognitive function and mood in ecstasy and marijuana users. Her postdoctoral research, which focused on characterizing the acute effects of MDMA (ecstasy) in humans, was undertaken at the University of Chicago. From 2009 until 2017, she was a faculty member of the Division on Substance Use Disorders at Columbia University Medical Center/New York State Psychiatric Institute in NYC. Dr. Bedi’s research interests include emerging substance use disorders in young people, behavioural pharmacology of substance use and abuse, and neurobehavioral processes contributing to substance use disorders.
Find out more about Gill Bedi's experience
Gill Bedi's highlights
Gill Bedi's selected work
An Open-Label Pilot Study Of Sub-Anaesthetic Ketamine For Methamphetamine Abuse In Young P..
The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in h..
Displaying the 3 most recent projects by Gill Bedi.
Displaying the 56 most recent scholarly works by Gill Bedi.
Individual differences in distress, impulsivity, and coping motives for use as predictors of problematic ecstasy use
Sally Meikle, Olivia Carter, Gillinder Bedi
Journal article | 2020 | Addictive Behaviors
BACKGROUND: Ecstasy users who report problematic use of ecstasy experience adverse social, psychological, and health-related conse..
Tobacco smoking in young people seeking treatment for mental ill-health: what are their attitudes, knowledge and behaviours towards quitting?
E Brown, B O'Donoghue, SL White, A Chanen, G Bedi, S Adams, C Schely, TU Do, A Sterjovska, K Moeller-Saxone, F Kay-Lambkin, M Simmons, E Cementon, E Killackey
Journal article | 2020 | Irish Journal of Psychological Medicine
INTRODUCTION: Tobacco smoking is a leading cause of preventable death and disease worldwide. Adults with mental ill-health smoke t..
Detection of acute 3,4-methylenedioxymethamphetamine (MDMA) effects across protocols using automated natural language processing
Carla Agurto, Guillermo A Cecchi, Raquel Norel, Rachel Ostrand, Matthew Kirkpatrick, Matthew J Baggott, Margaret C Wardle, Harriet de Wit, Gillinder Bedi
Journal article | 2020 | Neuropsychopharmacology
Social motivational processing and interpersonal function in aging cocaine smokers
Gillinder Bedi, Xuejun Hao, Nicholas T Van Dam, Ziva D Cooper, Eric Rubin, Nehal P Vadhan, Leslie Marino, Margaret Haney
Journal article | 2019 | Addiction Biology
Illicit drug use among aging cohorts is increasing, yet little is known about functional impairments in older drug users. Given th..
Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse
Evan S Herrmann, Ziva D Cooper, Gillinder Bedi, Divya Ramesh, Stephanie Collins Reed, Sandra D Comer, Richard W Foltin, Margaret Haney
Journal article | 2019 | Addiction Biology
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis
Margaret Haney, Robert J Malcolm, Sharma Babalonis, Paul A Nuzzo, Ziva D Cooper, Gillinder Bedi, Kevin M Gray, Aimee McRae-Clarke, Michelle R Lofwall, Steven Sparenborg, Sharon L Walsh
Journal article | 2016 | Neuropsychopharmacology
Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users
Evan S Herrmann, Ziva D Cooper, Gillinder Bedi, Divya Ramesh, Stephanie C Reed, Sandra D Comer, Richard W Foltin, Margaret Haney
Journal article | 2016 | Psychopharmacology
Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study
Gillinder Bedi, Richard W Foltin, Erik W Gunderson, Judith Rabkin, Carl L Hart, Sandra D Comer, Suzanne K Vosburg, Margaret Haney
Journal article | 2010 | Psychopharmacology
Snr Res Fellow: Addiction And Youth Mental Health
Centre For Youth Mental Health
Doctor of Psychology (Clinical)
Bachelor of Arts/Bachelor of Science (Hons)